Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms
Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresh...
Saved in:
Published in | Archives of osteoporosis Vol. 19; no. 1; p. 39 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
Springer London
16.05.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1862-3514 1862-3522 1862-3514 |
DOI | 10.1007/s11657-024-01392-5 |
Cover
Abstract | Summary
In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators.
Introduction
The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence.
Material
The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years.
Results
During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools.
Conclusion
The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures. |
---|---|
AbstractList | In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators.In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators.The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence.INTRODUCTIONThe aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence.The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years.MATERIALThe study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years.During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools.RESULTSDuring the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools.The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures.CONCLUSIONThe current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures. In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. INTRODUCTION: The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. MATERIAL: The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. RESULTS: During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. CONCLUSION: The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures. Summary In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. Introduction The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. Material The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. Results During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. Conclusion The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures. In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of 457 women. Using the rigid threshold of 10% showed a significant discrepancy in sensitivity and specificity of all tools. New thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds allow for improving the diagnostic accuracy of all three calculators. The aim of the longitudinal, retrospective study was to compare three tools designed to assess fracture risk: FRAX, Garvan, and POL-RISK in their prediction of fracture incidence. The study group consisted of 457 postmenopausal women with a mean age of 64.21 ± 5.94 years from the Gliwice Osteoporosis (GO) Study. Comprehensive data on clinical factors related to fractures were collected for all participants. Bone densitometry was performed at the proximal femur using the Prodigy device (GE, USA). Fracture risk was established using the FRAX, Garvan, and POL-RISK algorithms. Data on the incidence of osteoporotic fractures were collected over the last 10 years. During the period of observation 72, osteoporotic fractures occurred in 63 subjects. For a preliminary comparison of the predictive value of analyzed diagnostic tools, the fracture risk threshold of 10% was used. For FRAX, the fracture probability exceeding 10% was observed only in 11 subjects who experienced fractures; thus, the fracture was properly predicted only in 22.9% of women. For Garvan, the respective value was 90.5%, and for POL-RISK, it was 98.4%. That gave a very low true positive value for FRAX and a very high false positive value for Garvan and POL-RISK. Based on ROC curves, new thresholds for high risk of fractures were established for each calculator separately: 6.3% for FRAX major fracture, 20.0% for Garvan any fracture, and 18.0% for POL-RISK any fracture. Such thresholds improve the diagnostic accuracy of all compared fracture prediction tools. The current study showed that different fracture risk assessment tools, although having similar clinical purposes, require different cut-off thresholds for making therapeutic decisions. Better identification of patients requiring therapy based on such an approach may help reduce the number of new fractures. |
ArticleNumber | 39 |
Author | Drozdzowska, B. Pluskiewicz, W. Werner, A. Adamczyk, P. Bach, M. |
Author_xml | – sequence: 1 givenname: W. orcidid: 0000-0003-1839-6560 surname: Pluskiewicz fullname: Pluskiewicz, W. email: wpluskiewicz@sum.edu.pl organization: Department and Clinic of Internal Diseases, Diabetology, and Nephrology, Metabolic Bone Diseases Unit, Faculty of Medical Sciences in Zabrze, Medical University of Silesia – sequence: 2 givenname: A. orcidid: 0000-0001-6098-0088 surname: Werner fullname: Werner, A. organization: Department of Applied Informatics, Silesian University of Technology – sequence: 3 givenname: M. orcidid: 0000-0002-6239-7790 surname: Bach fullname: Bach, M. organization: Department of Applied Informatics, Silesian University of Technology – sequence: 4 givenname: P. orcidid: 0000-0001-9557-221X surname: Adamczyk fullname: Adamczyk, P. organization: Department of Pediatrics, Faculty of Medical Sciences in Katowice, Medical University of Silesia – sequence: 5 givenname: B. orcidid: 0000-0002-2287-6842 surname: Drozdzowska fullname: Drozdzowska, B. organization: Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38755326$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1rFDEAxYNU7If-Ax4kRw-dmo9JMuNFSnG3xYWVVsFbyGaS3dSZZEwyLQX_eLNuK9VDPSUh7_d48N4h2PPBGwBeY3SCERLvEsaciQqRukKYtqRiz8ABbjipKMP13qP7PjhM6RohjjDjL8A-bQRjlPAD8HMWlc5TNDC69B2O0XROZxc8dB6OIeXB-DCqKake3obygDaGAc6X8CpP3d17mDcG6jCMqvCFWpl8a4pqdnn67RjOVbxR_hgq38HPy0V1eXH1Cap-HaLLmyG9BM-t6pN5dX8ega-zj1_OzqvFcn5xdrqodN2gXFluVwRZjTva1pStVEs7jrUmjDRYNF1jlSa07jjVnBlkqaopbik1thUW8ZYegQ8733FaDabTxueoejlGN6h4J4Ny8u8f7zZyHW4kxqhtGiGKw9t7hxh-TCZlObikTd8rb8KUJMWMcsGFYP-XIsY5x4LWRfrmca4_gR7qKYJmJ9AxpBSNldplta2nxHS9xEhulyB3S5BlCfL3EuQ2BvkHfXB_EqI7KBWxX5sor8MUfenmKeoXpxHGTA |
CitedBy_id | crossref_primary_10_4239_wjd_v15_i9_1962 |
Cites_doi | 10.1111/ijcp.14009 10.1007/s00198-019-05088-2 10.1007/s11606-018-4696-z 10.1097/MD.0000000000003415 10.1007/s00198-007-0362-8 10.1016/j.afos.2018.03.001 10.1002/jbmr.371 10.1007/s00198-019-04919-6 10.1136/bmj.i6755 10.1016/j.bone.2010.02.012 10.1016/j.jocd.2017.06.023 10.1002/jbmr.215 10.5603/EP.2017.0062 10.1136/bmjopen-2021-060282 10.1007/s00198-021-05941-3 10.1002/jbmr.1956 10.1007/s00198-007-0543-5 10.1016/j.maturitas.2015.12.003 10.1359/jbmr.2000.15.4.721 10.1002/jbm4.10532 10.1002/jbmr.4432 10.1016/j.maturitas.2013.10.021 10.1016/j.jocd.2017.07.005 10.1007/s11657-023-01346-3 10.1007/s00198-008-0588-0 10.3109/13685538.2013.875991 10.20452/pamw.16395 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 2024. The Author(s). |
Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
DOI | 10.1007/s11657-024-01392-5 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic AGRICOLA MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1862-3514 |
EndPage | 39 |
ExternalDocumentID | PMC11098877 38755326 10_1007_s11657_024_01392_5 |
Genre | Journal Article Comparative Study |
GroupedDBID | --- -5E -5G -BR -EM -~C .VR 06C 06D 0R~ 0VY 1N0 203 23N 29~ 2J2 2JN 2KG 2KM 2LR 2~H 30V 4.4 406 408 40D 53G 5GY 67Z 6NX 875 8TC 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANZL AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACCUX ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACZOJ ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEFQL AEGAL AEGNC AEJHL AEJRE AEMSY AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AIAKS AIGIU AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BGNMA BSONS C6C CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI ESBYG F5P FEDTE FERAY FFXSO FIGPU FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXD IZQ J-C J0Z JBSCW JZLTJ KDC KOV LLZTM M4Y NPVJJ NQJWS NU0 O93 O9I O9J P2P P9S PF0 PT4 QOR QOS R89 R9I RPX RSV S16 S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 TSG TSK TT1 TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WK8 YLTOR Z45 Z7U Z87 ZMTXR ZOVNA ~A9 ~KM AAPKM AAYXX ABBRH ABDBE ABFSG ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION EMOBN ROL ABRTQ CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c480t-f6fb20fc1d39435ba93d61cc2528178d8fac234d63c65e0f3a431933ef97f0693 |
IEDL.DBID | U2A |
ISSN | 1862-3514 1862-3522 |
IngestDate | Thu Aug 21 18:35:38 EDT 2025 Fri Aug 22 20:23:37 EDT 2025 Tue Aug 05 09:48:47 EDT 2025 Mon Jul 21 06:01:38 EDT 2025 Tue Jul 01 01:01:07 EDT 2025 Thu Apr 24 23:07:29 EDT 2025 Fri Feb 21 02:36:13 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Women Osteoporosis FRAX Fracture prediction POL-RISK Garvan |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c480t-f6fb20fc1d39435ba93d61cc2528178d8fac234d63c65e0f3a431933ef97f0693 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6098-0088 0000-0001-9557-221X 0000-0003-1839-6560 0000-0002-6239-7790 0000-0002-2287-6842 |
OpenAccessLink | https://link.springer.com/10.1007/s11657-024-01392-5 |
PMID | 38755326 |
PQID | 3056661734 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11098877 proquest_miscellaneous_3153676775 proquest_miscellaneous_3056661734 pubmed_primary_38755326 crossref_citationtrail_10_1007_s11657_024_01392_5 crossref_primary_10_1007_s11657_024_01392_5 springer_journals_10_1007_s11657_024_01392_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-05-16 |
PublicationDateYYYYMMDD | 2024-05-16 |
PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-16 day: 16 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Archives of osteoporosis |
PublicationTitleAbbrev | Arch Osteoporos |
PublicationTitleAlternate | Arch Osteoporos |
PublicationYear | 2024 |
Publisher | Springer London |
Publisher_xml | – name: Springer London |
References | MG Donaldson (1392_CR7) 2011; 26 ND Nguyen (1392_CR4) 2008; 19 L Iconaru (1392_CR23) 2022; 37 C Beaudoin (1392_CR9) 2019; 30 W Pluskiewicz (1392_CR14) 2014; 17 1392_CR6 ND Nguyen (1392_CR3) 2007; 18 G Todorow (1392_CR22) 2022; 12 W Pluskiewicz (1392_CR25) 2021; 32 KH Rubin (1392_CR8) 2013; 28 JA Kanis (1392_CR2) 2008; 19 1392_CR27 MJ Bolland (1392_CR15) 2011; 26 N Dagan (1392_CR21) 2017; 356 R Lorenc (1392_CR26) 2017; 68 KL Holloway-Kew (1392_CR19) 2019; 30 CM Klotzbuecher (1392_CR1) 2000; 15 CJ Crandall (1392_CR18) 2018; 34 TV Nguyen (1392_CR11) 2017; 20 TACM van Geel (1392_CR16) 2014; 77 SY Chen (1392_CR10) 2016; 95 W Pluskiewicz (1392_CR28) 2023; 18 W Pluskiewicz (1392_CR13) 2010; 46 P Adamczyk (1392_CR5) 2018; 21 F Baleanu (1392_CR20) 2021; 5 EO Billington (1392_CR17) 2016; 85 TV Nguyen (1392_CR12) 2018; 4 W Pluskiewicz (1392_CR24) 2021; 75 |
References_xml | – volume: 75 start-page: 14009 year: 2021 ident: 1392_CR24 publication-title: Int J Clin Pract doi: 10.1111/ijcp.14009 – volume: 30 start-page: 2129 year: 2019 ident: 1392_CR19 publication-title: Osteoporos Int doi: 10.1007/s00198-019-05088-2 – volume: 34 start-page: 235 year: 2018 ident: 1392_CR18 publication-title: J Gen Intern Med doi: 10.1007/s11606-018-4696-z – volume: 95 start-page: e3415 issue: 20 year: 2016 ident: 1392_CR10 publication-title: Medicine doi: 10.1097/MD.0000000000003415 – volume: 18 start-page: 1109 year: 2007 ident: 1392_CR3 publication-title: Osteoporos Int doi: 10.1007/s00198-007-0362-8 – volume: 4 start-page: 2 year: 2018 ident: 1392_CR12 publication-title: Osteoporosis and Sarcopenia doi: 10.1016/j.afos.2018.03.001 – volume: 26 start-page: 1767 year: 2011 ident: 1392_CR7 publication-title: J Bone Miner Res doi: 10.1002/jbmr.371 – volume: 30 start-page: 721 year: 2019 ident: 1392_CR9 publication-title: Osteoporos Int doi: 10.1007/s00198-019-04919-6 – volume: 356 start-page: i6755 year: 2017 ident: 1392_CR21 publication-title: BMJ doi: 10.1136/bmj.i6755 – volume: 46 start-page: 1661 year: 2010 ident: 1392_CR13 publication-title: Bone doi: 10.1016/j.bone.2010.02.012 – volume: 20 start-page: 368 year: 2017 ident: 1392_CR11 publication-title: J Clin Densitom doi: 10.1016/j.jocd.2017.06.023 – volume: 26 start-page: 420 year: 2011 ident: 1392_CR15 publication-title: J Bone Miner Res doi: 10.1002/jbmr.215 – volume: 68 start-page: 1 year: 2017 ident: 1392_CR26 publication-title: Endokrynol Pol doi: 10.5603/EP.2017.0062 – ident: 1392_CR27 – volume: 12 start-page: e060282 year: 2022 ident: 1392_CR22 publication-title: BMJ Open doi: 10.1136/bmjopen-2021-060282 – volume: 32 start-page: 2043 year: 2021 ident: 1392_CR25 publication-title: Osteoporos Int doi: 10.1007/s00198-021-05941-3 – volume: 28 start-page: 1701 year: 2013 ident: 1392_CR8 publication-title: J Bone Miner Res doi: 10.1002/jbmr.1956 – volume: 19 start-page: 385 year: 2008 ident: 1392_CR2 publication-title: Osteoporos Int doi: 10.1007/s00198-007-0543-5 – volume: 85 start-page: 11 year: 2016 ident: 1392_CR17 publication-title: Maturitas doi: 10.1016/j.maturitas.2015.12.003 – volume: 15 start-page: 721 year: 2000 ident: 1392_CR1 publication-title: J Bone Miner Res doi: 10.1359/jbmr.2000.15.4.721 – volume: 5 start-page: e10532 issue: 9 year: 2021 ident: 1392_CR20 publication-title: JBMR Plus (WOA) doi: 10.1002/jbm4.10532 – volume: 37 start-page: 59 year: 2022 ident: 1392_CR23 publication-title: J Bone Miner Res doi: 10.1002/jbmr.4432 – volume: 77 start-page: 174 year: 2014 ident: 1392_CR16 publication-title: Maturitas doi: 10.1016/j.maturitas.2013.10.021 – volume: 21 start-page: 213 issue: 2 year: 2018 ident: 1392_CR5 publication-title: J Clin Densitom doi: 10.1016/j.jocd.2017.07.005 – volume: 18 start-page: 136 issue: 1 year: 2023 ident: 1392_CR28 publication-title: Arch Osteoporos doi: 10.1007/s11657-023-01346-3 – volume: 19 start-page: 1431 year: 2008 ident: 1392_CR4 publication-title: Osteoporos Int doi: 10.1007/s00198-008-0588-0 – volume: 17 start-page: 174 year: 2014 ident: 1392_CR14 publication-title: Aging Male doi: 10.3109/13685538.2013.875991 – ident: 1392_CR6 doi: 10.20452/pamw.16395 |
SSID | ssj0060156 |
Score | 2.3197327 |
Snippet | Summary
In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a... In the longitudinal, retrospective study, the ability of the FRAX, Garvan, and POL-RISK algorithms to predict osteoporotic fractures was compared in a group of... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 39 |
SubjectTerms | Absorptiometry, Photon - statistics & numerical data Aged Algorithms Bone Density densitometry Endocrinology Female femur Humans Incidence Longitudinal Studies Medicine Medicine & Public Health Middle Aged Original Original Article Orthopedics osteoporosis Osteoporosis, Postmenopausal - complications Osteoporosis, Postmenopausal - epidemiology Osteoporotic Fractures - epidemiology Postmenopause prediction Retrospective Studies risk risk assessment Risk Assessment - methods Risk Factors Sensitivity and Specificity therapeutics |
Title | Fracture risk prediction in postmenopausal women from GO Study: the comparison between FRAX, Garvan, and POL-RISK algorithms |
URI | https://link.springer.com/article/10.1007/s11657-024-01392-5 https://www.ncbi.nlm.nih.gov/pubmed/38755326 https://www.proquest.com/docview/3056661734 https://www.proquest.com/docview/3153676775 https://pubmed.ncbi.nlm.nih.gov/PMC11098877 |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBdrC2MvY91X021Bg70tAsv6sLy3NNTp1rUd3QLZk5FkaQ20ToiTh0H_-OocOyXtCOzJD5ZkrJPufsfd_Q6hT4mizCdGEOM0IzyxjgQr54hMeWypNEKmUOB8di5PRvzbWIyborCqzXZvQ5K1pr4vdqNSJCTYFAKwJbhQO2hPBN8druMo7rf6V0JxcFMe8-95myboEa58nB75IEZam57sBXreYEbcXwl5Hz1x5Uv09KyJir9CtxmUOi3nDkOiOJ7N4Q1sOJ6UeDatIJE8-MbLKixSMy5gKCrBwwsMWYR_v-AAArFdNyTETe4Wzi774x4eQvegsod1WeAfF9_J5defp1hf_5nOJ4urm-o1GmXHvwYnpOmqQCxX0YJ46U0ceUsLlgasZHTKCkmtjUWsaKIK5bWNGS8ks1K4yDMdMEbKmPNp4iOZsjdot5yW7gBho1KlpNJGc8-1jrQWnFtXUKZNKgvXQbTd6Nw2lOPQ-eI6vydLBuHkQTh5LZxcdNDn9ZzZinBj6-iPrfzycC8g2KFLN11WObhGAXskjG8ZE9Q9ENYlYZ23K5mvv8mCIycCtu0gtXEa1gOAl3vzTTm5qvm5gcQ16O6kg3rtwckbzVBt-ZfD_xv-Dj2L60MtCJXv0e5ivnQfAkBamC7a62dHR-fwHP4-Pe6inYEcdOtbcgcwLg1j |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDCa2FNh62Xtt9tSA3RYVtvWw3FswNEmXpB26BshOhiTLa9DOCWL7sGE_vpJjp0g7BOhZD1sSJX4EyY8An0PhkzRUDCsjCaahNthqOYN5RAPtc8V45BKcxyd8MKHfpmxaJ4XlTbR745KsXuqbZDefsxBbnYIdbLEm1EPYodYG91qw0-3_HB41LzB36cF1gsz_R24qoTvI8m6A5C0vaaV8ek9h0vz2Kubk8qAs1IH-e4vR8b7regZPajSKuivxeQ4PTPYCHo1rf_tL-NdzSVTl0iAXgo4WS9fijhLNMrSY5y5E3VrdZW4nqbgckEtXQf1T5OIT_xwiCy-RXpc6RHVUGOqddacd1Hd1ibIOklmCvp-O8NnxjyGSV7_my1lx8Tt_BZPe0fnXAa7rNWBNhVfglKcq8FLtJySyKEzJiCTc1zpggfBDkYhU6oDQhBPNmfFSIi16iQgxaRSmHo_Ia2hl88zsA1IiEoILqSRNqZSelIxSbRKfSBXxxLTBbw4w1jWZuaupcRXf0DC7bY3ttsbVtsasDV_WYxYrKo-tvT81chHbG-fcKDIz8zKPndFlUU1I6JY-VpE4KrzQzrO3kqX1N4k1EZlFzW0QG1K27uAYvzdbstlFxfzt6GGtVgjb0GlkKa7fnHzLWt7cr_tHeDw4H4_i0fHJ8C3sBpVoMuzzd9AqlqV5b2FYoT7Ut-4aZH8pXw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwELZgkVZcEG_K00jcqLVx_IjNrQKyu-xTC5V6i2zHZistadWkByR-PJ406VIWVeLssaN4xuPP8nyfEXqXKcpCZgWx3jDCM-dJ3OU8kZqnjkorpAaC88mpPBjzLxMx-YPF31a791eSK04DqDRVzd68DHvXxDcqRUbi_kIAwsTj1G10J6ZjCpE-Tkd9LpZAFO6oMv_ut7kd3cCYN0sl_7ovbbeh_D661-FHPFo5_AG65auHaPekuyF_hH7lQHtaLjyGonE8X0ALTD6eVng-q6GoPJ6Tl3UcpFVfwEAwwftnGCoKf37AERBit36cEHd1XDi_GE2GeB9eEqqG2FQlPj87JheHX4-wufo-W0ybyx_1YzTOP3_7eEC6FxaI4yppSJDBpklwtGQ64iZrNCsldS4VqaKZKlUwLmW8lMxJ4ZPATMQbmjEfdBYSqdkTtFPNKv8MYau0UlIZa3jgxiTGCM6dLykzVsvSDxDtJ7pwnfw4vIJxVVwLJ4NziuiconVOIQbo_brPfCW-sdX6be-_Iq4RuPgwlZ8t6wKOSRGHZIxvsYmpH8TrsjjO05XP199k8VAnIs4dILURDWsD0OjebKmml61WNwi6xjyeDdCwD5yiyxL1ln95_n_mb9Du-ae8OD48PXqB7qZtfAtC5Uu00yyW_lXETY193S6N3_jmEKU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fracture+risk+prediction+in+postmenopausal+women+from+GO+Study%3A+the+comparison+between+FRAX%2C+Garvan%2C+and+POL-RISK+algorithms&rft.jtitle=Archives+of+osteoporosis&rft.au=Pluskiewicz%2C+W.&rft.au=Werner%2C+A.&rft.au=Bach%2C+M.&rft.au=Adamczyk%2C+P.&rft.date=2024-05-16&rft.issn=1862-3514&rft.eissn=1862-3514&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1007%2Fs11657-024-01392-5&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11657_024_01392_5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1862-3514&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1862-3514&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1862-3514&client=summon |